These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 19096960)

  • 41. MicroRNAs and future therapeutic applications in cancer.
    Casalini P; Iorio MV
    J BUON; 2009 Sep; 14 Suppl 1():S17-22. PubMed ID: 19785062
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Micro-RNAs: The new potential biomarkers in cancer diagnosis, prognosis and cancer therapy.
    Mansoori B; Mohammadi A; Shirjang S; Baradaran B
    Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):1-10. PubMed ID: 26475381
    [TBL] [Abstract][Full Text] [Related]  

  • 43. miRNA: small molecules as potential novel biomarkers in cancer.
    Shah AA; Leidinger P; Blin N; Meese E
    Curr Med Chem; 2010; 17(36):4427-32. PubMed ID: 21062260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNAs in oral cancer: Biomarkers with clinical potential.
    Yete S; Saranath D
    Oral Oncol; 2020 Nov; 110():105002. PubMed ID: 32949853
    [TBL] [Abstract][Full Text] [Related]  

  • 45. OncomiRs: the discovery and progress of microRNAs in cancers.
    Cho WC
    Mol Cancer; 2007 Sep; 6():60. PubMed ID: 17894887
    [TBL] [Abstract][Full Text] [Related]  

  • 46. dbDEMC: a database of differentially expressed miRNAs in human cancers.
    Yang Z; Ren F; Liu C; He S; Sun G; Gao Q; Yao L; Zhang Y; Miao R; Cao Y; Zhao Y; Zhong Y; Zhao H
    BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S5. PubMed ID: 21143814
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Versatile applications of microRNA in anti-cancer drug discovery: from therapeutics to biomarkers.
    Iguchi H; Kosaka N; Ochiya T
    Curr Drug Discov Technol; 2010 Jun; 7(2):95-105. PubMed ID: 20836759
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNAs, an active and versatile group in cancers.
    Liu J; Zheng M; Tang YL; Liang XH; Yang Q
    Int J Oral Sci; 2011 Oct; 3(4):165-75. PubMed ID: 22010574
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Emerging roles for modulation of microRNA signatures in cancer chemoprevention.
    Neelakandan K; Babu P; Nair S
    Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. microRNA Therapeutics in Cancer - An Emerging Concept.
    Shah MY; Ferrajoli A; Sood AK; Lopez-Berestein G; Calin GA
    EBioMedicine; 2016 Oct; 12():34-42. PubMed ID: 27720213
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cancer therapy via modulation of micro RNA levels: a promising future.
    Kota SK; Balasubramanian S
    Drug Discov Today; 2010 Sep; 15(17-18):733-40. PubMed ID: 20692360
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [MicroRNA in Various Aspects of Cancer Development].
    Nambara S; Mimori K
    Gan To Kagaku Ryoho; 2017 May; 44(5):362-366. PubMed ID: 28536328
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNAs in osteosarcoma.
    Zhang J; Yan YG; Wang C; Zhang SJ; Yu XH; Wang WJ
    Clin Chim Acta; 2015 Apr; 444():9-17. PubMed ID: 25661090
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [MicroRNA in Body Fluids - Development of the Novel Plat Form for Cancer Therapeutics and Diagnosis].
    Takahashi RU; Prieto-Vila M; Kohama I; Ochiya T
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):899-905. PubMed ID: 30026410
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiRNA-based Therapeutics for Lung Cancer.
    Wu M; Wang G; Tian W; Deng Y; Xu Y
    Curr Pharm Des; 2018 Feb; 23(39):5989-5996. PubMed ID: 28714413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.
    Yao D; Jiang Y; Gao S; Shang L; Zhao Y; Huang J; Wang J; Yang S; Chen L
    Cell Prolif; 2016 Oct; 49(5):541-53. PubMed ID: 27436709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating cell-free microRNAs as clinical cancer biomarkers.
    Armand-Labit V; Pradines A
    Biomol Concepts; 2017 May; 8(2):61-81. PubMed ID: 28448269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression profile of MicroRNA: An Emerging Hallmark of Cancer.
    Zaheer U; Faheem M; Qadri I; Begum N; Yassine HM; Al Thani AA; Mathew S
    Curr Pharm Des; 2019; 25(6):642-653. PubMed ID: 30914015
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Small players with big roles: microRNAs as targets to inhibit breast cancer progression.
    Greene SB; Herschkowitz JI; Rosen JM
    Curr Drug Targets; 2010 Sep; 11(9):1059-73. PubMed ID: 20545613
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Tumor-associated circulating microRNAs as biomarkers of cancer.
    Wang J; Zhang KY; Liu SM; Sen S
    Molecules; 2014 Feb; 19(2):1912-38. PubMed ID: 24518808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.